Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Ionomr Innovations Inc. maintains 2 pending office actions in the Chemistry & Materials technology area. These matters are split between 2 distinct examiners and 2 distinct art units. ZHANG, MICHAEL N is the busiest examiner with 1 pending office action.
Each of the 2 pending actions is currently assigned to a different examiner and art unit. This distribution indicates that the company's active matters are being evaluated independently across 2 distinct technical groups within the chemistry sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG, MICHAEL N | 1 | 54.5% | +22.5% |
| WHEELER, THURMAN MICHAEL | 1 | 45.8% | +23.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18551105 | ANTIVIRAL AND ANTIMICROBIAL COATINGS AND METHODS THEREOF | WHEELER, THURMAN MICHAEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18933694 | CROSS-LINKED ARYLIMIDAZOLIUM POLYMERS AND USES THEREOF | ZHANG, MICHAEL N | — |
| 18551105 | ANTIVIRAL AND ANTIMICROBIAL COATINGS AND METHODS THEREOF | WHEELER, THURMAN MICHAEL | — |
| Art Unit | Apps |
|---|---|
| 1781 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18933694 | CROSS-LINKED ARYLIMIDAZOLIUM POLYMERS AND USES THEREOF | ZHANG, MICHAEL N | 1781 | §112 | Non-Final OA | — | Pending | Oct 31, 2024 |
| 18551105 | ANTIVIRAL AND ANTIMICROBIAL COATINGS AND METHODS THEREOF | WHEELER, THURMAN MICHAEL | 1619 | §103§112 | Non-Final OA | — | Pending | Sep 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIonomr Innovations Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Michael N Zhang has the most, with 1 of Ionomr Innovations Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
